World supplier of antibodies, antigens and kits since 2007
Signal Inhibitors and Activators
FK-506 (Tacrolimus)
$211.2/ 50mg
QuantityTotal: $211
Ship worldwide. Contact order@enogene.com for ordering and bulk pricing or contact your local distributor.
Product Information
Kinase Inhibitor Name FK-506 (Tacrolimus)
Biological ActivityPimecrolimus caused a strong and dose-dependent inhibition of anti-IgE–induced release of histamine from mast cells and basophils (maximally 73% and 82%, respectively, at 500 nmol/L pimecrolimus) and of mast cell tryptase (maximally 75%) and a less pronounced inhibition of LTC4 (maximally 32%) and of calcium ionophore plus phorbol myristate acetate–induced mast cell TNF-α release (90% maximum at 100 nmol/L pimecrolimus). [1]
In the pig model, topical SDZ ASM 981 was as effective as the ultrapotent corticosteroid clobetasol-17-propionate, and when compared with a series of commercial topical corticosteroid preparations, 0.1% SDZ ASM 981 had equivalent efficacy to clobetasol-17-propionate (0.05%), the most potent product on the market. Unlike the corticosteroid, however, SDZ ASM 981 did not cause skin atrophy in pigs. [2]
SDZ ASM 981 inhibits the proliferation of human T cells after antigen-specific or non-specific stimulation. It downregulates the production of Th1 [interleukin (IL)-2, interferon-γ] and Th2 (IL-4, IL-10) type cytokines after antigen-specific stimulation of a human T-helper cell clone isolated from the skin of an atopic dermatitis patient. SDZ ASM 981 inhibits the phorbol myristate acetate/phytohaemagglutinin-stimulated transcription of a reporter gene coupled to the human IL-2 promoter in the human T-cell line Jurkat and the IgE/antigen-mediated transcription of a reporter gene coupled to the human tumour necrosis factor (TNF)-α promoter in the murine mast-cell line CPII. [3]
In the pig model, topical SDZ ASM 981 was as effective as the ultrapotent corticosteroid clobetasol-17-propionate, and when compared with a series of commercial topical corticosteroid preparations, 0.1% SDZ ASM 981 had equivalent efficacy to clobetasol-17-propionate (0.05%), the most potent product on the market. Unlike the corticosteroid, however, SDZ ASM 981 did not cause skin atrophy in pigs. [2]
SDZ ASM 981 inhibits the proliferation of human T cells after antigen-specific or non-specific stimulation. It downregulates the production of Th1 [interleukin (IL)-2, interferon-γ] and Th2 (IL-4, IL-10) type cytokines after antigen-specific stimulation of a human T-helper cell clone isolated from the skin of an atopic dermatitis patient. SDZ ASM 981 inhibits the phorbol myristate acetate/phytohaemagglutinin-stimulated transcription of a reporter gene coupled to the human IL-2 promoter in the human T-cell line Jurkat and the IgE/antigen-mediated transcription of a reporter gene coupled to the human tumour necrosis factor (TNF)-α promoter in the murine mast-cell line CPII. [3]
M.W. 810.45 Formula: C43H68ClNO11 Solubility: DMSO Purity: 98% Storage: at -20℃ 2 years CAS No.: 137071-32-0
References[1] Torsten Zuberbier et al. Journal of Allergy and Clinical Immunology. 2001 August;108(2):275-280
[2] Meingassner J. G. et al. British Journal of Dermatology.1997, 137(4):568 – 576
[3] Grassberger M et al. Br J Dermatol. 1999 Aug; 141(2):264-73
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.
[2] Meingassner J. G. et al. British Journal of Dermatology.1997, 137(4):568 – 576
[3] Grassberger M et al. Br J Dermatol. 1999 Aug; 141(2):264-73
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.
Price211.2$
Research AreaStem Cells Cancer Cardiovascular Cell Biology Epigenetics & Nuclear Signaling Developmental Biologys Immunology Drug Discovery Products Metabolism Neuroscience Signal Transduction
![caused a strong and dose-dependent inhibition of anti-IgE–induced cells and basophils (maximally 73% and 82%, respectively, mast cell tryptase (maximally 75%) and a less pronounced of calcium ionophore plus phorbol myristate acetate–induced at 100 nmol/L pimecrolimus). [1] topical SDZ ASM 981 was as effective as the ultrapotent and when compared with a series of commercial](/img/pdfimg/E1KS5003/E1KS5003-001.jpg)
caused a strong and dose-dependent inhibition of anti-IgE–induced cells and basophils (maximally 73% and 82%, respectively, mast cell tryptase (maximally 75%) and a less pronounced of calcium ionophore plus phorbol myristate acetate–induced at 100 nmol/L pimecrolimus). [1] topical SDZ ASM 981 was as effective as the ultrapotent and when compared with a series of commercial
Categories by research area
Categories by product type
- Antibodies
- Primary Antibodies
- Tag antibodies
- Internal control antibodies
- Pathological (Immunohistochemistry, IHC) antibodies
- Cell Signal Transduction Research Antibodies
- Secondary Antibody
- Antibody Sampler Kits
- ELISA Kits
- Recombinant Proteins
- Fluorescence Reagents
- Signal Inhibitors and Activators
- Transfection Reagent
- Cell biology kits
- Overexpression Cell Lines
- Cell Lysates
- Purification Resins
- 2019-nCoV & Monkeypox